Genotyping Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Genetics is of extreme importance to medical practice as it provides a definitive diagnosis for many clinically heterogeneous diseases. Consequently, it enables a more precise disease prognosis and provides guidance towards the selection of the best therapeutic choices for the affected patients. Much of its current promise comes from its ability to examine the human genome at various stages, from chromosome to single-base changes. Furthermore, Genetic testing assists with developing preventative health plans, reducing health care costs for patients such as chronic disease detection and management in the long run. Health systems reduce health care costs while still providing high-quality care by utilizing resources like Genome Medical.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21794

According to UnivDatos Market Insights (UMI)’ research report “Global Genotyping Market Analysis, 2021”, the Genotypingmarket is projected to grow at a CAGR of ~20% during 2021-27F. Deteriorating health coupled with the rising cost of medical treatment is one of the major reasons of concern across the globe owing to the advancement in medical technology. These factors are driving the worldwide demand for cost-effective healthcare solutions augmenting the growth of the genotyping market globally.

Based on product/services, the market is fragmented into Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics. The reagent & kits segment held significant growth in 2020 owing to the increasing demand for the reagents, sampling, and sequencing process of the genomes. However, during the forecast period, the bioinformatics segment is predicted to have lucrative growth. This is mainly due to the increasing demand for better and improved software in healthcare as well as in the diagnostic sector to store the genetic information of the patient.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21794

Sequencing Segment to Witness Robust growth

Based on technology, the market is segmented into PCR, sequencing, electrophoresis, microarray, and others. The PCR grabbed a major market share in the genotyping market in 2020. This is mainly due to the rapidly increasing incidences of genetic diseases among the population and the continuously developing infrastructure for medical diagnostics owing to the growth of the PCR segment. Furthermore, during the forecast period, the sequencing segment is predicted to have a considerable share in genotyping market due to the continuous enhancement in the sequencing technology and increasing investment in biotechnology.

Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, hospitals and clinics, academic & government institutes, diagnostic & research institutions, and others. The pharmaceutical & biotechnology companies are held a significant share in the market in 2020. This is mainly due to increasing the need for pharmacogenomics in the drug development process and the increasing demand for specific medicines is responsible for the segmental growth in 2020. During the forecast period, the diagnostic & research institution segment is anticipated to have a significant growth in the genotyping market. The increasing cases of the diseases such as cancer induce the demand for the proper diagnostic tests along with advancements in genetics attributed to the significant market size of the segment in the future.

For more informative information, please visit us – https://univdatos.com/report/genotyping-market/

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global genotyping market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the well-established market players and frequent product launches. North America is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Genotyping Market Analysis, 2021”.  

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Genotyping Market include lllumina Inc., Thermo Fisher Scientific Inc., Qiagen Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, Agilent Technologies, Eurofins Scientific Inc., GE Healthcare Inc., and Bio-Rad Laboratories Inc,, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Genotyping Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for genotyping providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/genotyping-market/

Market Segmentation:

1.     By Product/Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics.)

2.     By Technology (PCR, Sequencing, Electrophoresis, Microarray, and Others)

3.     By End-users (Pharmaceutical & Biotechnology Companies, Hospitals And Clinics, Academic & Government Institutes, Diagnostic & Research Institutions, and Others)

4.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.     By Company (lllumina Inc., Thermo Fisher Scientific Inc., Qiagen Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, Agilent Technologies, Eurofins Scientific Inc., GE Healthcare Inc., and Bio-Rad Laboratories Inc.etc.)

Key questions answered in the study:

1.     What are the current and future trends in the genotyping industry?

2.     How the industry has been evolving in terms of product/service, technology, and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the genotyping industry?

5.     What is the customer orientation, purchase behavior, and expectations from the genotyping firms across various regions? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL GENOTYPING MARKET COVID-19 IMPACT

6 GLOBAL GENOTYPING MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT/SERVICE TYPE

8 MARKET INSIGHTS BY TECHNOLOGY

9 MARKET INSIGHTS BY END-USERS

10 MARKET INSIGHTS BY REGION

11 GENOTYPING MARKET DYNAMICS

12 GENOTYPING MARKET OPPORTUNITIES

13 GENOTYPING MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Healthcare Cloud Computing Market to Reach US$ 80.5 Billion by 2027 Globally |CAGR: 14.5%| 

·       Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%| 

·       Preventive Healthcare Technologies and Services Market to Reach US$ 493.1 Billion by 2027 Globally |CAGR: 10.5%| 

·       Internet of Medical Things Market to Reach US$ 284.5 Billion by 2027 Globally | CAGR: 18.5% |